• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗膀胱癌的流行病学和组织学趋势。

The epidemiological and histological trend of bladder cancer in Iran.

作者信息

Rafiemanesh Hosein, Lotfi Zahra, Bakhtazad Sima, Ghoncheh Mahshid, Salehiniya Hamid

机构信息

Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Department of Biotechnology, Guilan University of Medical Sciences, Rasht, Iran.

出版信息

J Cancer Res Ther. 2018 Apr-Jun;14(3):532-536. doi: 10.4103/0973-1482.172134.

DOI:10.4103/0973-1482.172134
PMID:29893311
Abstract

INTRODUCTION

Bladder cancer is the ninth common cancer in the world, the third common cancer among men in the Arabic and Western Asian countries, and the second in some regions of Iran (a country in the Middle East). There was no study on the epidemiological and histological trend of bladder cancer in Iran. This study aimed to the epidemiological and histological trend of bladder cancer in Iran.

MATERIALS AND METHODS

In this study, data were extracted from annual cancer registry reports of Iranian Ministry of Health between 2003 and 2008. Standardized incidence rates were calculated using the world standard population and incidence rate was calculated by age groups, sex, and histological type. Data on epidemiologic trend and histology were analyzed using Joinpoint software package.

RESULTS

A total of 23,291 cases were reported. Almost 17.70% (4127 cases) were women and 82.30% (19,170 cases) men. The sex ratio (male to female) was 4.65. Joinpoint analysis showed the significant increased trend of age-standardized incidence rate (ASIR) for both sexes. The annual percentage change of standardized incidence rate was 11.5 (confidence interval [CI]: 9.0-14.0) in women and 10.8 (CI: 8.0-13.6) in men. Two histological types of transitional cell carcinoma (TCC), not otherwise specified and papillary TCC included 43.89% and 49.86% of all cancer cases, respectively.

CONCLUSION

According to this study the trend of ASIR of bladder cancer in Iran is rising, so it is necessary to conduct further researches in future to provide accurate information on the cancer and investigate related risk factors and implement prevention programs in Iran.

摘要

引言

膀胱癌是全球第九大常见癌症,在阿拉伯和西亚国家中是男性第三大常见癌症,在伊朗(中东国家)的一些地区则是第二大常见癌症。此前尚无关于伊朗膀胱癌流行病学和组织学趋势的研究。本研究旨在探讨伊朗膀胱癌的流行病学和组织学趋势。

材料与方法

在本研究中,数据取自伊朗卫生部2003年至2008年的年度癌症登记报告。使用世界标准人口计算标准化发病率,并按年龄组、性别和组织学类型计算发病率。使用Joinpoint软件包分析流行病学趋势和组织学数据。

结果

共报告了23291例病例。其中女性占近17.70%(4127例),男性占82.30%(19170例)。男女比例为4.65。Joinpoint分析显示,两性的年龄标准化发病率(ASIR)均呈显著上升趋势。女性标准化发病率的年百分比变化为11.5(置信区间[CI]:9.0 - 14.0),男性为10.8(CI:8.0 - 13.6)。两种未另行指定的移行细胞癌(TCC)组织学类型和乳头状TCC分别占所有癌症病例的43.89%和49.86%。

结论

根据本研究,伊朗膀胱癌的ASIR呈上升趋势,因此未来有必要进一步开展研究,以提供有关该癌症的准确信息,调查相关危险因素,并在伊朗实施预防计划。

相似文献

1
The epidemiological and histological trend of bladder cancer in Iran.伊朗膀胱癌的流行病学和组织学趋势。
J Cancer Res Ther. 2018 Apr-Jun;14(3):532-536. doi: 10.4103/0973-1482.172134.
2
The Trend in Histological Changes and the Incidence of Esophagus Cancer in Iran (2003-2008).伊朗食管癌的组织学变化趋势与发病率(2003 - 2008年)
Int J Prev Med. 2016 Feb 8;7:31. doi: 10.4103/2008-7802.175990. eCollection 2016.
3
A descriptive retrospective study of bladder cancer at a hospital in Iran (1973-2003).伊朗一家医院膀胱癌的描述性回顾性研究(1973 - 2003年)
Asian Pac J Cancer Prev. 2009 Oct-Dec;10(4):681-4.
4
Prostate Cancer in Iran: Trends in Incidence and Morphological and Epidemiological Characteristics.伊朗的前列腺癌:发病率、形态学及流行病学特征的趋势
Asian Pac J Cancer Prev. 2016;17(2):839-43. doi: 10.7314/apjcp.2016.17.2.839.
5
Incidence Trend and Epidemiology of Common Cancers in the Center of Iran.伊朗中部常见癌症的发病率趋势与流行病学
Glob J Health Sci. 2015 Jul 13;8(3):146-55. doi: 10.5539/gjhs.v8n3p146.
6
Epidemiologic status of bladder cancer in Shiraz, southern Iran.伊朗南部设拉子膀胱癌的流行病学状况
Asian Pac J Cancer Prev. 2011;12(5):1323-7.
7
Breast Cancer in Iranian Woman: Incidence by Age Group, Morphology and Trends.伊朗女性乳腺癌:按年龄组、形态学及趋势划分的发病率
Asian Pac J Cancer Prev. 2016;17(3):1393-7. doi: 10.7314/apjcp.2016.17.3.1393.
8
Bladder Cancer Incidence in Iran: Results of the Iranian National Population-Based Cancer Registry from 2014 to 2016.伊朗膀胱癌发病率:2014 年至 2016 年伊朗全国基于人群的癌症登记处的结果。
Urol J. 2021 Oct 13;19(4):274-280. doi: 10.22037/uj.v18i.6760.
9
Epidemiology and trend of cancers in the province of Kerman: southeast of Iran.伊朗东南部克尔曼省癌症的流行病学与趋势
Asian Pac J Cancer Prev. 2015;16(4):1409-13. doi: 10.7314/apjcp.2015.16.4.1409.
10
Breast Cancer Trend in Iran from 2000 to 2009 and Prediction till 2020 using a Trend Analysis Method.2000年至2009年伊朗乳腺癌发病趋势及运用趋势分析方法对2020年的预测。
Asian Pac J Cancer Prev. 2016;17(3):1493-8. doi: 10.7314/apjcp.2016.17.3.1493.

引用本文的文献

1
Incidence trends, histological subtypes, and topographical distribution of bladder cancer in Iran: a study based on the Iranian National Cancer Registry during 2006-2015.伊朗膀胱癌的发病率趋势、组织学亚型及部位分布:一项基于2006 - 2015年伊朗国家癌症登记处数据的研究
Front Oncol. 2024 Oct 8;14:1423968. doi: 10.3389/fonc.2024.1423968. eCollection 2024.
2
Occult urothelial carcinoma with mediastinal metastasis: A case report.隐匿性尿路上皮癌伴纵隔转移:一例报告。
Oncol Lett. 2024 Feb 9;27(4):148. doi: 10.3892/ol.2024.14281. eCollection 2024 Apr.
3
Cancer patterns in Iran: a gender-specific spatial modelling of cancer incidence during 2014-2017.
伊朗的癌症模式:2014-2017 年癌症发病率的性别特异性空间建模。
BMC Cancer. 2024 Feb 12;24(1):191. doi: 10.1186/s12885-024-11940-4.
4
TERT Promoter Mutations as Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region.TERT 启动子突变作为一种简单、非侵入性的尿生物标志物,用于在高风险地区检测尿路上皮膀胱癌。
Int J Mol Sci. 2022 Nov 18;23(22):14319. doi: 10.3390/ijms232214319.
5
Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran.阿片类药物使用与膀胱癌风险:伊朗的一项多中心病例对照研究。
Int J Epidemiol. 2022 Jun 13;51(3):830-838. doi: 10.1093/ije/dyac031.
6
Survey of Mast Cell Density in Transitional Cell Carcinoma.移行细胞癌中肥大细胞密度的调查
Iran J Pathol. 2021 Spring;16(2):119-127. doi: 10.30699/IJP.2020.123562.2345. Epub 2020 Dec 20.
7
Five-Year Survival Rate of Bladder Cancer in Iran during 2001-2007.2001 - 2007年伊朗膀胱癌的五年生存率
Iran J Pathol. 2021 Winter;16(1):69-74. doi: 10.30699/ijp.2020.118375.2287. Epub 2020 Oct 10.
8
Establishment of a bladder cancer cell line expressing both mesenchymal and epithelial lineage-associated markers.建立一种同时表达间充质和上皮谱系相关标志物的膀胱癌细胞系。
Hum Cell. 2021 Mar;34(2):675-687. doi: 10.1007/s13577-020-00456-1. Epub 2020 Nov 9.
9
Diagnostic accuracy of NMP 22 and urine cytology for detection of transitional cell carcinoma urinary bladder taking cystoscopy as gold standard.以膀胱镜检查为金标准,评估NMP 22和尿液细胞学检查对膀胱移行细胞癌的诊断准确性。
Pak J Med Sci. 2020 May-Jun;36(4):705-710. doi: 10.12669/pjms.36.4.1638.
10
Genetic and molecular biology of bladder cancer among Iranian patients.伊朗患者膀胱癌的遗传和分子生物学。
Mol Genet Genomic Med. 2020 Jun;8(6):e1233. doi: 10.1002/mgg3.1233. Epub 2020 Apr 6.